Sanofi (SNY) reported Q2 business earnings Thursday of 2.09 euros ($2.39) per share, up from 1.59 euros a year earlier.
Three analysts polled by FactSet expected 1.83 euros.
Net sales for the quarter ended June 30 were $11.60 billion, compared with $9.99 billion a year earlier.
Analysts surveyed by FactSet expected 11.52 billion euros.
For 2026, the company raised its sales guidance to around 10% from a high single-digit percentage growth. Analysts surveyed by FactSet expect 48.89 billion euros.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments